Loading...
Cefpodoxime 100mg+Potassium Clavulanate 62.50 mg Dry Syrup
A maximum-strength, dual-action antibacterial dry syrup designed for the intensive treatment of severe and highly resistant pediatric infections. EXLLA CV 100 DS combines a double-dose of a third-generation cephalosporin with a potent beta-lactamase inhibitor to ensure clinical victory against bacteria that have developed advanced defense mechanisms.
A maximum-strength, dual-action antibacterial dry syrup designed for the intensive treatment of severe and highly resistant pediatric infections. EXLLA CV 100 DS combines a double-dose of a third-generation cephalosporin with a potent beta-lactamase inhibitor to ensure clinical victory against bacteria that have developed advanced defense mechanisms.
EXLLA CV 100 DS utilizes the ultimate combination of Cefpodoxime and Potassium Clavulanate. While Cefpodoxime works to destroy the bacterial cell wall, the 62.50mg of Clavulanate acts as a sterile shield, neutralizing the beta-lactamase enzymes that "superbugs" produce to protect themselves. This synergy ensures that the antibiotic remains 100% active against highly resistant strains.
Cefpodoxime 100mg is a potent, double-strength cephalosporin known for its superior tissue penetration. This higher concentration is specifically designed for older children or severe clinical cases, providing a faster onset of action and a higher success rate in treating deep-seated infections.
EXLLA CV 100 DS is a gold-standard choice for treating complicated middle ear infections (Otitis Media), resistant sinusitis, and community-acquired pneumonia. It effectively eliminates pathogens like H. influenzae and Moraxella catarrhalis that frequently cause treatment failure with standard antibiotics.
The dry syrup format preserves the maximum potency of the active ingredients until the moment of use. Once reconstituted, it ensures rapid absorption into the bloodstream, reaching the site of infection quickly to reduce high-grade fever, severe pain, and localized inflammation within the first few doses.
This formulation provides a robust defense against a wide array of Gram-positive and Gram-negative bacteria. It is particularly effective for pediatric patients who have a history of recurrent infections or who have recently completed a course of standard antibiotics without full recovery.
The "100 DS" concentration allows for the administration of a smaller volume of syrup to reach high therapeutic levels. This is critical for improving patient compliance in children who are severely ill or have difficulty swallowing larger amounts of liquid, ensuring the full treatment course is completed.
Indication Severe and Resistant Otitis Media, Complicated Acute Sinusitis and Tonsillitis, Community-Acquired Pneumonia, Recurrent Urinary Tract Infections (UTIs), Skin and Soft Tissue Infections, Typhoid Fever and Bronchial Flare-ups.
Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.
Amoxycillin Trihydrate 400g+ Clavulanic Acid 57mg
Amoxycillin 200 mg +Potassium Clavulanic 28.5 mg+ Lactic Acid Bacillus 60 Million Spores
